Reports
Sale
Europe Protein Expression Market Size, Share, Growth, Trends: By Product: Expression Vectors, Competent Cells, Reagents, Instruments, Services; By Application: Industrial, Research, Therapeutic; By System Type: Mammalian Cell Expression System, Others; By End User; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Europe Protein Expression Market Outlook
The global protein expression market size was valued at USD 3 billion in 2023, with Europe holding a significant market share. The market is driven by the increased protein-based research and development activities across the region. It is expected to grow at a CAGR of 5.40% during the forecast period of 2024-2032, with the values likely to attain USD 4.9 billion by 2032.
Key Takeaways
- The market is poised toward an upwards trajectory due to increased investment activities in the region. The German government invested EUR 38 million (nearly USD 41 million) in the protein transition in the 2024 federal budget.
- The Europe protein expression market share is likely to be driven by increasing partnership activities between market players. The market players strategically collaborating to increase the production of spider silk proteins, are predicted to play a pivotal role in the biomedical, cosmetics, and textiles industries.
- The opening of a new state-of-the-art protein production facility by BioAscent is anticipated to significantly fuel the market growth, indicating the prevalence of infrastructure improvements and investments.
Europe Protein Expression Market Analysis
The market is poised to be driven by the heavy government investments in the protein transition to support and promote alternative proteins. The investment is focused on human nutrition, expanding public research for plant-based foods and cultivated meat, and establishing the Proteins-of-the-Future Centre. In November 2023, the Budget Committee of the German Bundestag announced an EUR 38 million (nearly USD 41 million) investment for protein transition in the federal budget 2024. This strategic move may significantly impact the Europe healthcare domain. The technologies used in the production of alternative proteins can also be used to produce pharmaceutical proteins, contributing to the Europe protein expression market growth.
The market is witnessing significant moves by market players influencing the market. For example, In February 2024, BioAscent, a leading provider of integrated drug discovery services opened its state-of-the-art protein production facility. This move showcased the latest investment made by the company enhancing its in-house drug discovery capabilities with the ability to deliver protein production. The facility is announced to be run by well-experienced industry experts ensuring quality outcomes and propelling market growth. The investment in advanced technologies in the facility such as FPLC (fast protein liquid chromatography), high-pressure homogeniser, shaking incubators, along with a sonicator, and a Category II tissue culture lab, representing the involvement of technologically advanced equipment in the facility.
The Europe protein expression market share is projected to be driven by the rising demand for personalized therapeutics and the rapidly growing research and development activities that support protein expression. Additionally, the market is driven by strategic partnerships between market players to upscale the production and application of innovative materials in the healthcare sector. One such example is the strategic collaboration of AMSilk GmbH (Neuried, Germany), advanced materials specialist, and 21st.BIO (Copenhagen) biotech production specialist. The announcement was made in January 2024 about the companies coming together to accelerate the production of AMSilk’s E. coli-based recombinant spider silk protein. With the potential application of AMSilk's spider silk-based protein in biomedicals, this collaboration is poised to accelerate its production, potentially increasing its application in healthcare such as wound healing, and drug delivery systems among others. AMSilk's spider silk proteins, derived from plants, reduce CO2 emissions by 90%, use less land and water, and are animal-free, benefiting textiles, homecare, and biomedical industries.
Europe Protein Expression Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product | Expression vectors, Competent Cells, Reagents, Instruments, Services |
| Application | Industrial, Research, Therapeutics |
| System Type | Mammalian Cell Expression System, Yeast Cell Expression System, Insect Cell Expression System |
| End User | Academic Research, Contract Research Organizations, Pharmaceutical and Biotechnology Companies |
| Country | United Kingdom, Germany, France, Italy, Others |
Europe Protein Expression Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Merck KGaA
- Sartorius AG
- Lonza Group AG
- Oxford Expression Technologies Ltd.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Danaher Corporation
- Promega Corporation
- QIAGEN
- GenScript Biotech Corporation
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by System Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Europe Protein Expression Market Overview
3.1 Europe Protein Expression Market Historical Value (2017-2023)
3.2 Europe Protein Expression Market Forecast Value (2024-2032)
4 Europe Protein Expression Market Landscape*
4.1 Europe Neonatal Ventilators: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Europe Neonatal Ventilators: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
5 Europe Protein Expression Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Europe Protein Expression Market Segmentation (2017-2032)
6.1 Europe Protein Expression Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Expression Vectors
6.1.3 Competent Cells
6.1.4 Reagents
6.1.5 Instruments
6.1.6 Services
6.2 Europe Protein Expression Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Industrial
6.2.3 Research
6.2.4 Therapeutic
6.3 Europe Protein Expression Market (2017-2032) by System Type
6.3.1 Market Overview
6.3.2 Mammalian Cell Expression System
6.3.3 Yeast Cell Expression System
6.3.4 Insect Cell Expression System
6.4 Europe Protein Expression Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Academic Research
6.4.3 Contract Research Organizations
6.4.4 Pharmaceutical & Biotechnology Companies
6.5 Europe Protein Expression Market (2017-2032) by Country
6.5.1 Market Overview
6.5.2 United Kingdom
6.5.3 Germany
6.5.4 France
6.5.5 Italy
6.5.6 Others
7 United Kingdom Protein Expression Market (2017-2032)
7.1 United Kingdom Protein Expression Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Expression Vectors
7.1.3 Competent Cells
7.1.4 Reagents
7.1.5 Instruments
7.1.6 Services
7.2 United Kingdom Protein Expression Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Industrial
7.2.3 Research
7.2.4 Therapeutic
7.3 United Kingdom Protein Expression Market (2017-2032) by System Type
7.3.1 Market Overview
7.3.2 Mammalian Cell Expression System
7.3.3 Yeast Cell Expression System
7.3.4 Insect Cell Expression System
7.4 United Kingdom Protein Expression Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Academic Research
7.4.3 Contract Research Organizations
7.4.4 Pharmaceutical & Biotechnology Companies
8 Germany Protein Expression Market (2017-2032)
8.1 Germany Protein Expression Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Expression Vectors
8.1.3 Competent Cells
8.1.4 Reagents
8.1.5 Instruments
8.1.6 Services
8.2 Germany Protein Expression Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Industrial
8.2.3 Research
8.2.4 Therapeutic
8.3 Germany Protein Expression Market (2017-2032) by System Type
8.3.1 Market Overview
8.3.2 Mammalian Cell Expression System
8.3.3 Yeast Cell Expression System
8.3.4 Insect Cell Expression System
8.4 Germany Protein Expression Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Academic Research
8.4.3 Contract Research Organizations
8.4.4 Pharmaceutical & Biotechnology Companies
9 France Protein Expression Market (2017-2032)
9.1 France Protein Expression Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Expression Vectors
9.1.3 Competent Cells
9.1.4 Reagents
9.1.5 Instruments
9.1.6 Services
9.2 France Protein Expression Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Industrial
9.2.3 Research
9.2.4 Therapeutic
9.3 France Protein Expression Market (2017-2032) by System Type
9.3.1 Market Overview
9.3.2 Mammalian Cell Expression System
9.3.3 Yeast Cell Expression System
9.3.4 Insect Cell Expression System
9.4 France Protein Expression Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Academic Research
9.4.3 Contract Research Organizations
9.4.4 Pharmaceutical & Biotechnology Companies
10 Italy Protein Expression Market (2017-2032)
10.1 Italy Protein Expression Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Expression Vectors
10.1.3 Competent Cells
10.1.4 Reagents
10.1.5 Instruments
10.1.6 Services
10.2 Italy Protein Expression Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Industrial
10.2.3 Research
10.2.4 Therapeutic
10.3 Italy Protein Expression Market (2017-2032) by System Type
10.3.1 Market Overview
10.3.2 Mammalian Cell Expression System
10.3.3 Yeast Cell Expression System
10.3.4 Insect Cell Expression System
10.4 Italy Protein Expression Market (2017-2032) by End User
10.4.1 Market Overview
10.4.2 Academic Research
10.4.3 Contract Research Organizations
10.4.4 Pharmaceutical & Biotechnology Companies
11 Regulatory Framework
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication Year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by Year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Market Share by Top 5 Companies
16.2 Merck KGaA
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Sartorius AG
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Lonza Group AG
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Oxford Expression Technologies Ltd.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Thermo Fisher Scientific Inc.
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Agilent Technologies, Inc.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Danaher Corporation
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Promega Corporation
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 QIAGEN
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 GenScript Biotech Corporation
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
17 Europe Protein Expression Market – Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The Europe protein expression market is expected to be driven by the robust research and development activities in the global protein expression market, which is anticipated to grow at a CAGR of 5.40% during the forecast period of 2024-2032 and is likely to reach a market value of USD 4.9 billion by 2032.
The market demand is driven by the increasing preference for personalized medicines and growth in healthcare expenditure.
One of the significant trends in the market is the increasing investment activities by governments. Such as German government funding nearly 41 million USD in protein transition.
Products in the market include expression vectors, competent cells, reagents, instruments, and services.
They find wide applications in industrial, research, and therapeutic domains.
Various types of protein expression systems are mammalian cell expression systems, yeast cell expression systems, and insect cell expression systems.
End users in the market include academic research, contract research organizations, pharmaceutical and biotechnology companies.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy.
The key players in the market are Merck KGaA, Sartorius AG, Lonza Group AG, Oxford Expression Technologies Ltd., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Danaher Corporation, Promega Corporation, QIAGEN, and GenScript Biotech Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER